Continuation or reintroduction of an antineoplastic strategy after documented disease progression

Oncology. 2013;85(6):348-9. doi: 10.1159/000357057. Epub 2013 Dec 6.

Author

Maurie Markman¹

Affiliation

¹ Cancer Treatment Centers of America, Eastern Regional Medical Center, Philadelphia, Pa., USA.

PMID: 24335354
DOI: 10.1159/000357057

No abstract available

Publication types

Editorial

MeSH terms

Antineoplastic Agents / therapeutic use*
Disease Progression
Humans
Neoplasms / drug therapy*

Substances

Antineoplastic Agents